Standout Papers

PRMT4 promotes ferroptosis to aggravate doxorubicin-induced cardiomyopathy via inhibition of the Nrf2/GPX4 pathway 2022 2026 2023 2024217
  1. PRMT4 promotes ferroptosis to aggravate doxorubicin-induced cardiomyopathy via inhibition of the Nrf2/GPX4 pathway (2022)
    Yilong Wang, Shu Yan et al. Cell Death and Differentiation

Immediate Impact

3 by Nobel laureates 15 from Science/Nature 58 standout
Sub-graph 1 of 24

Citing Papers

Pyroptosis in health and disease: mechanisms, regulation and clinical perspective
2024 Standout
Targeting epigenetic and posttranslational modifications regulating ferroptosis for the treatment of diseases
2023 Standout
1 intermediate paper

Works of Yilong Wang being referenced

CHIP protects against septic acute kidney injury by inhibiting NLRP3-mediated pyroptosis
2023
PRMT4 promotes ferroptosis to aggravate doxorubicin-induced cardiomyopathy via inhibition of the Nrf2/GPX4 pathway
2022 Standout
and 1 more

Author Peers

Author Last Decade Papers Cites
Yilong Wang 398 242 102 165 34 859
Donghyun Kim 421 151 43 243 39 994
Yining Yang 423 131 16 225 68 1.0k
Erhui Jiang 548 267 105 416 46 1.1k
Weihai Liu 379 151 51 184 42 899
Lejia Sun 215 378 9 90 45 851
Wei‐Ping Lee 281 206 43 116 41 813
Yuepeng Zhou 415 207 95 253 45 873
Ziyi Wang 447 138 35 131 79 1.0k
Rutulkumar Patel 498 139 33 262 20 1.0k
Jae Hoon Park 644 266 9 177 24 1.1k

All Works

Loading papers...

Rankless by CCL
2026